(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid tert-butyl ester
- CAS125517-63-7
- CatalogueRS-I016081
- FormulaC13H22O5
- MW258.31
On this page
Product identification
| Product name | (6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid tert-butyl ester |
|---|---|
| Catalogue No. | RS-I016081 |
| CAS No. | 125517-63-7 |
| Molecular formula | C13H22O5 |
| Molecular weight | 258.31 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Pitavastatin |
| Also known as | tert-Butyl [(4RS,6SR)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate; Pitavastatin Impurity 8 |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-I016081 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Pitavastatin
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-I016081
- Request a quotation for RS-I016081
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Pitavastatin
All 91 further standards are listed here — every link is in the page, not loaded later.
-
Pitavastatin
BACK ORDERRS-U041147 -
Pitavastatin Sodium
IN STOCKRS-P045053 -
Pitavastatin USP Related Compound B
IN STOCKRS-P045014 -
((2-Cyclopropyl-4-phenylquinolin-3-yl)methyl)triphenylphosphonium bromide
BACK ORDERRS-U071119 -
(3S,5R)-Enantiomer of Pitavastatin Calcium
BACK ORDERRS-I011091 -
(E)-6-(2-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-4-hydroxytetrahydro-2H-pyran-2-one
CUSTOM SYNTHESISRS-M108084 -
(E)7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-(3R,5R)-dihydroxyhept-6-enic acid ethyl ester
CUSTOM SYNTHESISRS-U047662 -
(Z)-Pitavastatin
CUSTOM SYNTHESISRS-P045003 -
2-(4-Fluorobenzoyl)benzoic acid
IN STOCKRS-U014143 -
2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid
IN STOCKRS-I009170 -
2-Amino-4'-fluorobenzophenone mesylate salt
IN STOCKRS-U056786 -
2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinoline
BACK ORDERRS-Z399KJQ -
2-Cyclopropyl-4-(2-fluorophenyl)quinoline-3-carbaldehyde
IN STOCKRS-U006266 -
2-Cyclopropyl-4-(4-fluorophenyl)-3-quinoline-d5 3-Aldehyde
IN STOCKRS-I098243 -
2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol-d5
IN STOCKRS-Q012001 -
3-Cyclopropyl-3-oxopropanoic Acid Methyl Ester
IN STOCKRS-P001456 -
3-Cyclopropyl-3-oxopropanoic-d5 Acid Methyl Ester
CUSTOM SYNTHESISRS-I098253 -
4-(4-Fluorophenyl)-2-cyclopropylquinoline-3-carboxylic-d5 Acid Methyl Ester
CUSTOM SYNTHESISRS-I099066 -
5-Methyl-1,3,4-thiadiazol-2-ol
IN STOCKRS-P045049 -
5-Oxo-Pitavastatin Methyl Ester
BACK ORDERRS-P045059 -
Dehydropitavastatin Ethyl Ester
BACK ORDERRS-P045052 -
Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
IN STOCKRS-D115041 -
Pitavastatin (2153433-73-7)
IN STOCKRS-P045057 -
Pitavastatin (3S,5R)-Isomer Calcium Salt
IN STOCKRS-Z401GE2 -
Pitavastatin (3S,5S)-Isomer Calcium
IN STOCKRS-I001030 -
Pitavastatin (3S,5S)-Isomer tert-butyl Ester
IN STOCKRS-P045047 -
Pitavastatin 3-Oxo Ethyl EsterEthyl
IN STOCKRS-P045018 -
Pitavastatin 8-Hydroxy Impurity
BACK ORDERRS-P045041 -
Pitavastatin Benzophenanthridine Impurity
BACK ORDERRS-P045005 -
Pitavastatin Calcium Pentahydrate Reference Standard
IN STOCKRS-U041184 -
Pitavastatin D4
CUSTOM SYNTHESISRS-P045051 -
Pitavastatin Defuoro Impurity Calcium Salt
IN STOCKRS-P045013 -
Pitavastatin Ethyl Ester
BACK ORDERRS-I001083 -
Pitavastatin Ethyl Ester
IN STOCKRS-P045032 -
Pitavastatin Methyl Ester
IN STOCKRS-I001130 -
Pitavastatin N-Oxide
IN STOCKRS-P045026 -
Pitavastatin(Phenylethylamine Salt)
IN STOCKRS-U041148 -
tert-Butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
IN STOCKRS-P045011 -
tert-Butyl 2-((4S,6R)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
IN STOCKRS-P045001 -
Tert-Butyl 2-(rel-(4R,6R)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
IN STOCKRS-P045037 -
Pitavastatin Impurity 3
IN STOCKRS-P045006 -
Pitavastatin Impurity 6
IN STOCKRS-P108002 -
Pitavastatin Impurity 7
IN STOCKRS-P045016 -
Pitavastatin Impurity 8(R,S)
BACK ORDERRS-I001AEC -
Pitavastatin Impurity 13 (Pitavastatin 2,4,6-Triene Impurity)
IN STOCKRS-P045036 -
Pitavastatin Impurity 15
IN STOCKRS-P045008 -
Pitavastatin Impurity 17
IN STOCKRS-P045046 -
Pitavastatin Impurity 19
IN STOCKRS-I009087 -
Pitavastatin Impurity 24 Sodium Salt
BACK ORDERRS-P045055 -
Pitavastatin Impurity 28
IN STOCKRS-P045040 -
Pitavastatin Impurity 29
IN STOCKRS-P045028 -
Pitavastatin Impurity 35
BACK ORDERRS-I001AP6 -
Pitavastatin Impurity 36(free)
IN STOCKRS-P045004 -
Pitavastatin Impurity 53
BACK ORDERRS-I001BUW -
Pitavastatin Impurity 59
BACK ORDERRS-P045056 -
Pitavastatin Impurity 60
BACK ORDERRS-Z401CV7 -
Pitavastatin Impurity 62
IN STOCKRS-Z400C4E -
Pitavastatin Impurity 65
BACK ORDERRS-I001AE3 -
Pitavastatin Impurity 66
IN STOCKRS-P045007 -
Pitavastatin Impurity 69 (847849-72-3)
BACK ORDERRS-P045058 -
Pitavastatin Impurity 74
IN STOCKRS-P045033 -
Pitavastatin Impurity 76
IN STOCKRS-P045015 -
Pitavastatin Impurity 79
IN STOCKRS-P045043 -
Pitavastatin Impurity 85
IN STOCKRS-P045031 -
Pitavastatin Impurity 87
BACK ORDERRS-Z413P3S -
Pitavastatin Impurity 102
IN STOCKRS-P045009 -
Pitavastatin Impurity 104
IN STOCKRS-I001B8P -
Pitavastatin Impurity 109
BACK ORDERRS-I001A4H -
Pitavastatin Impurity 124
IN STOCKRS-P045062 -
Pitavastatin Impurity 124
BACK ORDERRS-Z398U8P -
Pitavastatin Impurity 136
BACK ORDERRS-P045050 -
Pitavastatin Impurity 138
BACK ORDERRS-P045034 -
Pitavastatin Impurity 160
IN STOCKRS-P045002 -
Pitavastatin Impurity 161
IN STOCKRS-P045010 -
Pitavastatin Impurity 162
IN STOCKRS-P045012 -
Pitavastatin Impurity 163
IN STOCKRS-P045017 -
Pitavastatin Impurity 165
IN STOCKRS-P045020 -
Pitavastatin Impurity 166
IN STOCKRS-P045021 -
Pitavastatin Impurity 167
IN STOCKRS-P045022 -
Pitavastatin Impurity 168
IN STOCKRS-P045023 -
Pitavastatin Impurity 169
IN STOCKRS-P045025 -
Pitavastatin Impurity 170
IN STOCKRS-P045029 -
Pitavastatin Impurity 171
IN STOCKRS-P045030 -
Pitavastatin Impurity 172
BACK ORDERRS-P045035 -
Pitavastatin Impurity 173
IN STOCKRS-P045038 -
Pitavastatin Impurity 174
IN STOCKRS-P045039 -
Pitavastatin Impurity 175
IN STOCKRS-P045042 -
Pitavastatin Impurity 176
IN STOCKRS-P045044 -
Pitavastatin Impurity 177
IN STOCKRS-P045045 -
Pitavastatin Impurity 178
IN STOCKRS-P045048 -
Pitavastatin Impurity 226
IN STOCKRS-P045054
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.






![Chemical structure of (E)7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-(3R,5R)-dihydroxyhept-6-enic acid ethyl ester](/structures/w4/MAUQAXOHCVNUMX-YIXGJFGDSA-N.webp?v=8)


![Chemical structure of 2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid](/structures/w4/HCQRTPSDEFPKCT-RQJHMYQMSA-N.webp?v=8)

![Chemical structure of 2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinoline](/structures/w4/MZRARJFFURJVLQ-UHFFFAOYSA-N.webp?v=8)














































































